Gynecologic Inflammation & Infections | Epidemiology
(Cost-)effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial
JM Munster*, ACAP Leenders, CJCM Hamilton, JCE Meekelenkamp, PM Schneeberger, W van der Hoek, A Rietveld, E de Vries, RP Stolk, JG Aarnoudse, E Hak
*Corresponding author: JM Munster
Obstetrics & Gynaecology, University Medical Center Groningen (UMCG), Groningen, Netherlands
F1000Posters 2013, 4: 32 (slide presentation) [English]
Slide Presentation [786.61 KB]
27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2011 , 14 - 17 Aug 2011, P000
University Medical Center Groningen (UMCG)
Q fever is a zoonosis, caused by the bacterium Coxiella burnetii. Between 2007 and 2010 over 3800 human Q fever cases were identified in the Netherlands. Pregnant women are one of the risk groups since both maternal and obstetric complications have been associated with the infection.
15% of the pregnant women living in high-risk Q fever areas in the Netherlands have serological evidence for a previous or acute C. burnetii infection
No relevant competing interests disclosed.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY Creative Commons 3.0 License